[Evaluation of the optimal fixed subsidies strategy for pneumococcal vaccination in the elderly]

Division of Health Technology Assessment, Center for Drug Evaluation, Taiwan
Record ID 32018011215
Chinese (Mandarin)
Authors' objectives: To compile the current status of pneumococcal vaccination under co-payment systems in various countries, evaluate the effectiveness of our countryˇ¦s fixed subsidy policy for pneumococcal vaccine implementation, and investigate elderly peopleˇ¦s views on fixed subsidies for pneumococcal vaccination, to serve as a reference for subsequent policy research and discussion.
Authors' results and conclusions: This report finds that all three fixed payment methods, compared to full payment for one dose of PPV23, are dominant strategies in the base analysis, i.e., under a fixed payment method with a certain vaccination rate, they are cost-saving strategies. Additionally, the questionnaire survey found that under a fixed subsidy of 1,000 TWD and an out-of-pocket payment of 3,000 TWD, 50% are willing to vaccinate. These results and findings can serve as a reference for subsequent related fixed payment pneumococcal vaccination policy planning.
Authors' recommendations: This report finds that all three fixed payment methods, compared to full payment for one dose of PPV23, are dominant strategies in the base analysis, i.e., under a fixed payment method with a certain vaccination rate, they are cost-saving strategies. Additionally, the questionnaire survey found that under a fixed subsidy of 1,000 TWD and an out-of-pocket payment of 3,000 TWD, 50% are willing to vaccinate. These results and findings can serve as a reference for subsequent related fixed payment pneumococcal vaccination policy planning.
Authors' methods: The current status of pneumococcal vaccination under co-payment systems in other countries is compiled through a literature review and web data retrieval to understand possible factors affecting vaccination rates. Additionally, a Markov model is constructed for cost-utility analysis from the payerˇ¦s perspective, with parameter estimates utilizing the Central Epidemic Command Centerˇ¦s statutory infectious disease case notification database and the National Health Insurance database to analyze the health status transition probabilities of the target population. This analysis also references public statistical data, related research, and expert opinions to collect the data required for the model. Furthermore, an online questionnaire survey is conducted to understand elderly peopleˇ¦s willingness to vaccinate against pneumococcal disease, their views on fixed payments, and their willingness to pay out-of-pocket.
Details
Project Status: Completed
Year Published: 2023
URL for published report: https://www.cde.org.tw/HTA/achievements
English language abstract: An English language summary is available
Publication Type: Full HTA
MeSH Terms
  • Pneumococcal Infections
  • Pneumococcal Vaccines
  • Aged
  • Mass Vaccination
  • Vaccination
  • Vaccination Coverage
Contact
Organisation Name: Center for Drug Evaluation
Contact Address: 3F.,No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. R.O.C.
Contact Name: Li Ying (Grace) Huang
Contact Email: lyhuang277@cde.org.tw
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.